Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 18, 2016

Study Completion Date

May 18, 2016

Conditions

Chronic Hepatitis B

Interventions

DRUG

NVR 3-778

DRUG

Placebo for NVR 3-778

Sugar pill manufactured to mimic the NVR 3-778 capsule

DRUG

Pegasys

Trial Locations (10)

Costa Mesa

Pasadena

San Diego

San Francisco

Hong Kong

Singapore

Chuncheon

Seongnam

Kaohsiung City

Keelung